Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 51
  • Journal CiteScore: 10.69
  • Journal Impact Factor: 9.13
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Type 2 Diabetes Mellitus: Sometimes the Diagnosis is not what it seems: Case Report

XX Congresso Regionale FADOI CAMPANIA: Non ci siamo mai fermati
Italy 2021

Cuomo Vincenzo, Dorato Maurizio, Meini Giuseppe and Ranucci Raffaele AN

UOC Medicina Interna, AFO Medica P.O. â�?�?S. Maria delle Grazieâ�?, Pozzuoli (NA), Italy

Posters & Accepted Abstracts: Health Sci J

Abstract:

Case history: 47-year-old male, smoker of about 15 cigarettes a day, BMI: 26. History of type 2 diabetes mellitus diagnosed at the age of 45. In home therapy with metformin and sulfonylureas, in poor glycometabolic compensation. Due to the appearance of epigastralgia and for frequent vomiting, he reaches our emergency room (Table 1); Diabetic ketoacidosis is diagnosed. Admitted to the Internal Medicine ward, on third day, the patient overcomes the acute event (table) and starts insulin therapy with Basal Bolus. Discussion: This patient had a diagnosis of type 2 diabetes mellitus but never achieve adequate glycemic compensation and he even has an episode of ketoacidosis. It is clear that the correct diagnosis is LADA, characterized by the presence of anti-GAD (Glutamic Acid Decarboxylase) or ICA (Islet Cell Antibody) or IA-2 (protein tyrosin phoshatase), onset after age 35 and insulin independence for at least 6 months after diagnosis. About 6-10% of patients initially defined as type 2 diabetics are actually suffering from autoimmune diabetes with a slow evolution towards insulin dependence. References 1. (2021) ADA Standards of Medical Care in Diabetes. Diabetes Care 44: S1-S2. 2. (2018) Standard Italiani per la cura del Diabete Mellito. SID – SMD.